LDLR and inherited lipid metabolism disorder: These miRNAs are emerging as new biomarkers for dyslipidaemia, and play significant roles in lipid metabolism by controlling the expressions of genes related to lipid metabolism, such as ATP-binding cassette subfamily A member 1 (ABCA1) and LDL receptor (LDLR) [229,230].